SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-18-044716
Filing Date
2018-02-14
Accepted
2018-02-14 11:25:03
Documents
1
Group Members
FLAGSHIP VENTURES FUND V GENERAL PARTNERS LLCNOUBAR B. AFEYAN, PH.D.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d540461dsc13g.htm SC 13G 62233
  Complete submission text file 0001193125-18-044716.txt   63880
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Subject) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90223 | Film No.: 18609087
SIC: 2836 Biological Products, (No Diagnostic Substances)